Main Article Content
Abstract
Keywords
Article Details
Copyright (c) 2020 Folia Medica Indonesiana
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
-
Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
You are free to :
Share ” copy and redistribute the material in any medium or format.
Adapt ” remix, transform, and build upon the material.
References
- AMRIN Study Group, 2005. Antimicrobial Resistance, Antibiotic Usage and Infection Control, A Self-Assessment Program For Indonesian Hospitals, Directorate of General Medical Care, Ministry of Health, Republic of Indonesia.
- Arce JM, Selva M, Perpinan H, Gubernado M, Armero CC, Quilez AL, Gonzales F&Vanaclocha H, 2011. Antimicrobial Resistance According to Age, Gender, Culture Site and Patient Location in more than 100.000 Escherichia coli. Antimicrobagent chemother; vol. 53: pp. 1222-1228
- Barbosa C, Trebosc V, Kemmer C, Rosenstiel P, Beardmore R, Schulenburg H & Jansen G,2017. Alternative Evolutionary Paths to Bacterial Antibiotic Resistance Cause Distinct Collateral Effects.MolBiolEvol, vol. 34, no. 9, pp. 2229-2244.
- Bruinsma N, Stobberingh E&P. de Smet, 2003. Antibiotics used and the prevalens of antibiotics resistance in bacteria from healthy volunteers in Dutch community. Infection; no. 1: pp. 9-14.
- Brunton LL, Chabner BA& Knolimam BC,2011. Goodman and Gilman's The Pharmacological Basis of Therapeutics: Chemotherapy of Microbial Diseases, 12th edn. McGraw-Hi11; chapter 7.
- DuerinkDO, Lestari ES, Hadi U, Nagelkerke NJ, Severin JA, Verbrugh HA, Keuter M, Gyssens IC &Broek PJ,2007. Determinant of carriage of resistance Escherichia coli in the Indonesian population inside and outside hospital. J Antimicrob Chemother ; vol. 60: pp. 377-384.
- Elaa M, Ferjani S, Jendoubi A, Hammami S, Hamzaoui Z, Saidani M, Houissa M, Slim A & Dubois V, 2016. High Prevalence of Gut Microbiota Colonization with Broad-Spectrum Cephalosporin Resistant Enterobacteriaceae in a Tunisian Intensive Care Unit.Front Microbiol; vol. 7, article 1859.
- Hadi U, 2009. Antibiotic usage and antimicrobial resistance in Indonesia, Doctoral thesis, Leiden University, Leiden-Netherland.
- Kemenkes RI, 2015. Program PengendalianResistensiAntimikroba Di RumahSakit, KementrianKesehatanRepublik Indonesia, Jakarta
- Kuntaman K, Lestari ES, Severin JA, Kershof IM, Mertaniasih NM, Purwanta M,Hadi U, Jonhson JR, Belkum AV&Verburgh HA,2005. Fluoroquinolon-Resistant Escherichia coli, Indonesia, Emerg Infect Dis; vol. 11, no. 9: pp. 1363-1369.
- Levy SB, 2002. Factors impacting on the problem of antibiotic resistance, J AntimicrobChemother;vol 49(1): 25-30
- DewantiL, Sulistiawati, Mariatul Q, Hari P, Kuntaman K, 2016. Kajianpenggunaanantibiotikadanpolaresistenbakteri flora usus di Puskesmas di Surabaya.KementrianKesehatanRepublik Indonesia, Jakarta.
- Penders J, Stobberingh EE, Savelkoul PH &Wolffs PF, 2013. The human microbiome as a reservoir of antimicrobial resistance.Front Microbiol, vol.4 pp. 87.
- Pedrera V, H. Schwarz, M. Pascual de la Torre, V. Gil-Gullen, D. Orozco, & JM. Caselles, 2004. Analysis of Antibiotic Use in The Community of Valencia (2000-2002). Enferm InfectMicrobiolClin; 22: 385-389
- WHO, 2012. The Evolving Threat of Antimicrobial Resistance Options for action, World Health Organization, Geneva.
- WHO SEARO, 2010. Regional Strategy on Prevention and Containment of Antimicrobial Resistance 2010-2015, WHO South East Asian Regional Office. New Delhi, India.
References
AMRIN Study Group, 2005. Antimicrobial Resistance, Antibiotic Usage and Infection Control, A Self-Assessment Program For Indonesian Hospitals, Directorate of General Medical Care, Ministry of Health, Republic of Indonesia.
Arce JM, Selva M, Perpinan H, Gubernado M, Armero CC, Quilez AL, Gonzales F&Vanaclocha H, 2011. Antimicrobial Resistance According to Age, Gender, Culture Site and Patient Location in more than 100.000 Escherichia coli. Antimicrobagent chemother; vol. 53: pp. 1222-1228
Barbosa C, Trebosc V, Kemmer C, Rosenstiel P, Beardmore R, Schulenburg H & Jansen G,2017. Alternative Evolutionary Paths to Bacterial Antibiotic Resistance Cause Distinct Collateral Effects.MolBiolEvol, vol. 34, no. 9, pp. 2229-2244.
Bruinsma N, Stobberingh E&P. de Smet, 2003. Antibiotics used and the prevalens of antibiotics resistance in bacteria from healthy volunteers in Dutch community. Infection; no. 1: pp. 9-14.
Brunton LL, Chabner BA& Knolimam BC,2011. Goodman and Gilman's The Pharmacological Basis of Therapeutics: Chemotherapy of Microbial Diseases, 12th edn. McGraw-Hi11; chapter 7.
DuerinkDO, Lestari ES, Hadi U, Nagelkerke NJ, Severin JA, Verbrugh HA, Keuter M, Gyssens IC &Broek PJ,2007. Determinant of carriage of resistance Escherichia coli in the Indonesian population inside and outside hospital. J Antimicrob Chemother ; vol. 60: pp. 377-384.
Elaa M, Ferjani S, Jendoubi A, Hammami S, Hamzaoui Z, Saidani M, Houissa M, Slim A & Dubois V, 2016. High Prevalence of Gut Microbiota Colonization with Broad-Spectrum Cephalosporin Resistant Enterobacteriaceae in a Tunisian Intensive Care Unit.Front Microbiol; vol. 7, article 1859.
Hadi U, 2009. Antibiotic usage and antimicrobial resistance in Indonesia, Doctoral thesis, Leiden University, Leiden-Netherland.
Kemenkes RI, 2015. Program PengendalianResistensiAntimikroba Di RumahSakit, KementrianKesehatanRepublik Indonesia, Jakarta
Kuntaman K, Lestari ES, Severin JA, Kershof IM, Mertaniasih NM, Purwanta M,Hadi U, Jonhson JR, Belkum AV&Verburgh HA,2005. Fluoroquinolon-Resistant Escherichia coli, Indonesia, Emerg Infect Dis; vol. 11, no. 9: pp. 1363-1369.
Levy SB, 2002. Factors impacting on the problem of antibiotic resistance, J AntimicrobChemother;vol 49(1): 25-30
DewantiL, Sulistiawati, Mariatul Q, Hari P, Kuntaman K, 2016. Kajianpenggunaanantibiotikadanpolaresistenbakteri flora usus di Puskesmas di Surabaya.KementrianKesehatanRepublik Indonesia, Jakarta.
Penders J, Stobberingh EE, Savelkoul PH &Wolffs PF, 2013. The human microbiome as a reservoir of antimicrobial resistance.Front Microbiol, vol.4 pp. 87.
Pedrera V, H. Schwarz, M. Pascual de la Torre, V. Gil-Gullen, D. Orozco, & JM. Caselles, 2004. Analysis of Antibiotic Use in The Community of Valencia (2000-2002). Enferm InfectMicrobiolClin; 22: 385-389
WHO, 2012. The Evolving Threat of Antimicrobial Resistance Options for action, World Health Organization, Geneva.
WHO SEARO, 2010. Regional Strategy on Prevention and Containment of Antimicrobial Resistance 2010-2015, WHO South East Asian Regional Office. New Delhi, India.